Kisspeptin

Hormonal Support Testosterone Libido Fertility LH Stimulation Reproductive Health

Daily or Pre-Event(1-2 hours prior)

SubQ

Starting from

R450

1 supplier available - see pricing tab below

View Pricing & Buy

Dosage

Daily or Pre-Event(1-2 hours prior)

Administration

SubQ

Category

Bioregulator

Overview

Kisspeptin-10 is a research peptide derived from the KISS1 gene, recognized as a master regulator of the hypothalamic-pituitary-gonadal (HPG) axis. It acts upstream of GnRH (gonadotropin-releasing hormone) and plays a central role in initiating puberty, regulating reproductive function, and supporting endogenous testosterone production. Kisspeptin-10 is the shortest bioactive fragment of the native kisspeptin protein, retaining full receptor binding activity at the KISS1R (GPR54) receptor.

Mechanism of Action

Kisspeptin binds to the KISS1R receptor on GnRH neurons in the hypothalamus, triggering the release of GnRH. GnRH then stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH signals the testes (or ovaries) to produce testosterone or estrogen, while FSH supports gametogenesis. Unlike exogenous testosterone or hCG, Kisspeptin works at the top of the hormonal cascade, preserving the body's natural feedback loops and downstream signaling architecture.

Key Benefits

Stimulates natural LH and FSH release via the HPG axis
Supports endogenous testosterone production
May enhance libido and sexual response
Supports fertility and reproductive function in research models
Preserves natural hormonal feedback unlike direct hormone replacement
Studied for mood and emotional response benefits
Potential application in post-cycle recovery research

Side Effects & Safety

Injection site redness, swelling, or irritation
Mild flushing or headache reported in some studies
Possible transient nausea at higher doses
Not recommended for individuals with hormone-sensitive conditions
Not approved for human use; sold strictly for research purposes
Long-term safety profile in humans has not been fully established
Consult a qualified medical professional before any use

Research & Stacking Notes

Pairs with CJC-1295 / Ipamorelin to support both GH and gonadal axes simultaneously Researched alongside PT-141 for combined libido and sexual response protocols Often explored in post-cycle therapy research as an alternative to hCG or SERMs Complements Tesamorelin or Sermorelin for comprehensive endocrine support Typical research dosing: 50-200 mcg per administration Acute protocols often use single doses pre-event; chronic protocols use daily or EOD dosing Reconstitute with bacteriostatic water; refrigerate after mixing Use within 2-3 weeks of reconstitution for peptide stability

Stacks Well With

Menotropin HMG

Bioregulator

Select your preferred supplier and add to cart. Prices shown include VAT.

Supplier / Lab	Strength / Volume	Price	Availability
UP UPA Labs Australia	5mg 1 Vial	R450	In Stock

All peptides are for research purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before use.